• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    ​Synthetic Cannabinoids 


    ​​Background:

    Synthetic cannabinoids are human-made, mind-altering chemicals that are sprayed on to dried plant material.  They can be smoked or sold as liquids to be vaporized in e-cigarettes and other devices.  These chemicals are called cannabinoids because they are similar to chemicals found in the marijuana plant.  The health effects from using synthetic cannabinoids can be unpredictable, harmful, and deadly.  ​Synthetic cannabinoids are also known as K2, spice, scooby snacks (or snax), synthetic marijuana, fake weed, and genie, among other names.

    In early March 2018, the Illinois Poison Center, along with the Illinois Department of Public Health, identified an outbreak of coagulopathies (bleeding disorders) among individuals who used synthetic cannabinoids found to be contaminated with a chemical used in some rat poisons (brodifacoum).  

    ​Since then, other states, including Maryland, have received reports of individuals who developed similar bleeding disorders after using synthetic cannabinoids.  Clinical signs from the Illinois and Maryland cases include bruising, nosebleeds, bleeding of the gums, bleeding out of proportion to the level of injury, vomiting blood, blood in urine or stool, or excessively heavy menstrual bleeding and back pain.  Of particular concern, the effects have been persistent, requiring prolonged treatment, and at this point there is no way to know which cannabinoids may be likely to cause the problem.  For that reason, the Department of Health is strongly discouraging any use of synthetic cannabinoids. 

    If anyone who has used synthetic cannabinoids in the past 3 months develops unexplained bleeding or bruising, it is recommended they:
    • ​Get immediate medical care at a hospital.
    • Contact the Maryland Poison Center at 800-222-1222.
    • Stop using and discard ANY synthetic cannabinoids.

    Healthcare providers should be aware of this situation and if patients present with unexplained bleeding:
    • ​Determine whether cases have used synthetic cannabinoids in the past 3 months.
    • Contact the Maryland Poison Center at 800-222-1222 to report cases and to obtain additional information on appropriate treatment.




    Information for Clinicians

    MDH Press Release
    Health Officials Warn Marylanders About the Continued Risks of Using Synthetic Cannabinoid Products

    Other Resources: